Skip Navigation LinksHome > March 2014 - Volume 33 - Issue 3 > A Consensus Statement: Meningococcal Disease Among Infants,...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000228
Consensus

A Consensus Statement: Meningococcal Disease Among Infants, Children and Adolescents in Latin America

Rüttimann, Ricardo Walter MD*; Gentile, Angela MD; Parra, Mercedes Macias MD; Saez-Llorens, Xavier MD§; Safadi, Marco Aurelio Palazzi MD, PhD; Santolaya, Maria Elena MD

Erratum

Erratum

In the article appearing on page 284,volume 33, issue 3, the figure source was cited incorrectly. Figure 1 on page 286 should be acknowledged as follows “Adapted from Ibarz-Pavón AB, Lemos AP, Gorla MC, Regueira M; SIREVA Working Group II, Gabastou JM. Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010. PLoS One. 2012;7:e44102.”

The Pediatric Infectious Disease Journal. 33(5):548, May 2014.

Collapse Box

Abstract

Invasive meningococcal disease is a serious infection that occurs worldwide. Neisseria meningitidis remains one of the leading causes of bacterial meningitis in all ages. Despite the availability of safe and effective vaccines against invasive meningococcal disease, few countries in Latin America implemented routine immunization programs with these vaccines. The Americas Health Foundation along with Fighting Infectious Disease in Emerging Countries recently sponsored a consensus conference. Six experts in infectious diseases from across the region addressed questions related to this topic and formulated the following recommendations: (1) standardized passive and active surveillance systems should be developed and carriage studies are mandatory; (2) a better understanding of the incidence, case fatality rates and prevalent serogroups in Latin America is needed; (3) countries should make greater use of the polymerase chain reaction assays to improve the sensitivity of diagnosis and surveillance of invasive meningococcal disease; (4) vaccines with broader coverage and more immunogenicity are desirable in young infants; (5) prevention strategies should include immunization of young infants and catch-up children and adolescents and (6) because of the crowded infant immunization schedule, the development of combined meningococcal vaccines and the coadministration with other infant vaccines should be explored.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.